
Seminars

Seminars
The Health System Node (HSN) coordinates seminars to foster collaboration and promote research development that aligns with the objectives of the HSN and strategic goals of the NIDA Clinical Trials Network (CTN). Seminars include presentations and discussions of emerging topics in substance use research, new trial methods, novel approaches to prevention, and to health service delivery for people who use substances, have substance use disorders, or are in recovery. Seminar presentations are given by national and international experts.
HSN Seminars typically occur on the first Thursday of each month from 10-11am PST (1-2pm EST). Please contact Morgan Ford if you would like to be added to the HSN seminar distribution list.
Upcoming Seminars
10/01/2026 10AM PT/1PM ET
MOUD During Critical Illness: What We Know, What We’re Finding, and Where We’re Headed
Ryan Buckley, MD, MPH
Join the Microsoft Teams Meeting here
Meeting ID: 250 658 877 216 6
Passcode: B8jq2m9A
Dial in by phone:
+1 213-533-9530, 508786770# United States, Los Angeles
Find a local number
Phone conference ID: 508 786 770#
02/04/2027 10AM PT/1PM ET
TBD
LaTrice Montgomery, PhD
Join the Microsoft Teams Meeting here
Meeting ID: 250 658 877 216 6
Passcode: B8jq2m9A
Dial in by phone:
+1 213-533-9530, 508786770# United States, Los Angeles
Find a local number
Phone conference ID: 508 786 770#
03/04/2027 10AM PT/1PM ET
Evaluating cannabis trajectories over 10 years of cannabis screening at KP Washington
Gwen Lapham, PhD, MSW, MPH
Join the Microsoft Teams Meeting here
Meeting ID: 250 658 877 216 6
Passcode: B8jq2m9A
Dial in by phone:
+1 213-533-9530, 508786770# United States, Los Angeles
Find a local number
Phone conference ID: 508 786 770#
Previous Seminars
| Date | Title | Speaker |
|---|---|---|
| 04/03/2025 | Studying Medications for Opioid Use Disorder Using Target Trial Emulation | Paul Christine, MD, PhD, and Marc LaRochelle, MD, MPH |
| 05/01/2025 | Improving Statistical Practice for Pragmatic Trials that Leverage Real-World Data to Evaluate Health System Interventions Addressing Substance Use Disorders | Jennifer Bobb, PhD |
| 06/30/2025 | Comprehensive and Innovative Options for Opioid Use Disorder Treatment in Switzerland | Marc Vogel, MD, MScPH |
| 10/02/2025 | Qualitative Research Insights into Structural Disempowerment Among People Who Use Drugs | Ricky N. Bluthenthal, PhD, and Sid S. Ganesh, PhD |
| 11/06/2025 | Lessons Learned About Treating Co-occurring Conditions Among Adults Receiving Substance Use Disorder Treatment | Mark A. Ilgen, PhD |
| 12/04/2025 | The Right Support at the Right Time: Just-in-Time Adaptive Interventions (JITAIs) for Substance Use | Kristina Phillips, PhD |
| 02/05/2026 | Best Practices for Engaging People who use Drugs as Research Partners and Participants | Kate LeMasters, PhD, and Betsy Craft, BS, CPFS |
| 04/02/2026 | Effects of Cannabis Legalization on Mental Health and Substance Use in Adults and Thoughts on Future Directions in Cannabis Research | Christian Hopfer, MD |
| 08/06/2026 | Rapid Rehousing and Substance-Related ED Use Among People Experiencing Homelessness in Connecticut | Caitlin Ryus, MD, MPH |
| 09/03/2026 | The Difference-Making Role of Staff Support in Implementing Nurse Care Management for Opioid Use Disorder Treatment: A Configurational Analysis | Tessa Matson, PhD, MPH |

NIDA Clinical Trials Network
4480 Hacienda Drive, Pleasanton, CA 94588
Contact: Monique Buffler
© 2026 CTNHSN.ORG | Your Privacy Choices